Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis of all common cancers. However, divergent outcomes exist between patients, suggesting distinct underlying tumor biology. Here, we ...
Identification of targetable molecular alterations in the NCI-COG Pediatric MATCH trial. Randomization of dose-reduced subcutaneous interleukin-2 (scIL2) in maintenance immunotherapy (IT) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results